Investment Thesis

.

Competitive Moat

. The company has established a robust network of laboratories and testing facilities that create significant switching costs for healthcare providers, who would face disruption and inefficiencies in changing providers. Additionally, Labcorp's brand recognition and regulatory compliance capabilities enhance its competitive advantage. Over the next 5-10 years, this moat appears durable, although emerging competitors offering lower-cost alternatives could pose a threat, particularly as telehealth and at-home testing gain traction.

Growth Engine

Future revenue growth for Labcorp is expected to stem from a broadening addressable market in diagnostics, projected to reach $50 billion by 2028, driven by an aging population and increased healthcare expenditures. The company is well-positioned to capitalize on organic growth through innovative product offerings and enhanced testing services, particularly in genetic and molecular testing. Moreover, strategic acquisitions to expand capabilities and geographic reach will further bolster its growth trajectory. Currently, Labcorp is gaining market share as healthcare providers increasingly prefer integrated solutions.